Artwork

Content provided by Anna Rehbein and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anna Rehbein and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1

3:18
 
Share
 

Manage episode 430520824 series 2512976
Content provided by Anna Rehbein and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anna Rehbein and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.

Show references:

https://doi.org/10.1016/s1474-4422(21)00159-9

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract

  continue reading

1468 episodes

Artwork
iconShare
 
Manage episode 430520824 series 2512976
Content provided by Anna Rehbein and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anna Rehbein and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.

Show references:

https://doi.org/10.1016/s1474-4422(21)00159-9

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract

  continue reading

1468 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide